Sangamo Therapeutics | search
Click here to view Sangamo Therapeutics news from 60+ newspapers.
Bookmark or Share- Genomic Medicine Clinical Trials - Sangamo Therapeutics, Inc.Sangamo is conducting several clinical trials to evaluate the safety, tolerability, and potential efficacy of its genomic medicines, some of which we lead and some of which are led by our global pharmaceutical company collaboration partners.
- Sangamo Therapeutics, Inc. | Pioneering Genetic CuresSangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene regulation.
- Careers | Join Sangamo| Sangamo Therapeutics, Inc.Join Sangamo and be a part of our team and grow with us. We believe Sangamo has a once-in-a-lifetime opportunity to transform the future of medicine. Sangamo and Astellas Announce Capsid License Agreement to Deliver Genomic Medicine for Neurological Diseases
- Our Mission | Sangamo Therapeutics, Inc.Sangamo is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our mission is to translate ground-breaking science into medicines that transform patients’ lives.
- Meet Our Leadership | Sangamo Therapeutics, Inc.Meet the Sangamo Therapeutics Management Team. Know our executive leadership team and board of directors here. Sangamo and Astellas Announce Capsid License Agreement to Deliver Genomic Medicine for Neurological Diseases
More
